Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00008216 · ClinicalTrials.gov registry record
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 48
- Enrollment target
NCT00008216: Clinical Trial study, sponsored by Columbia University.
NCT00008216 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00008216 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 48 participants
- Enrollment target
Study Summary
RATIONALE: Giving chemotherapy drugs and total-body irradiation before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. PURPOSE: This phase II trial is studying the effectiveness of donor peripheral blood stem cell transplant in treating patients with hematologic cancer.
Primary Outcome
Number of irreversible severe (grade 3) or life-threatening or lethal (grade 4-5) organ toxicities.
Interventions
- PROCEDURE Peripheral Blood Stem Cell Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 1996-07 |
| Est. Completion | 2009-01 |
Why NCT00008216 stopped before completion
NCT00008216 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Peripheral Blood Stem Cell Transplantation is the first listed.
NCT00008216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00008216 about?
NCT00008216 is a clinical study titled "Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer". RATIONALE: Giving chemotherapy drugs and total-body irradiation before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into ...
What is the current status of trial NCT00008216?
This trial is currently terminated. The enrollment target is 48 participants. The study started on 1996-07. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00008216?
The interventions under investigation include: Peripheral Blood Stem Cell Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00008216?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia